LIVN Stock Price, Chart, Stats & News

LivaNova PLC
Save
4.39B
Market cap
40.79x
Current P/E
18.59x
Forward P/E
LIVN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 68.04% |
Operating margin | 14.37% |
Pretax margin | -15.91% |
Net margin | -17.47% |
Effective tax rate | -9.83% |
ROA | -9.30% |
ROE | -21.49% |
D/E | 0.39x |
Interest coverage ratio | 3.43x |
LIVN valuation
P/E | 40.79x |
P/S | 2.44x |
P/B | 2.81x |
P/CF | 13.25x |
P/FCF | 19.52x |
P/OCF | 13.25x |
PEG | 1.21x |
EV multiple | -29.40x |
About
LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems.
Similar securities
Based on sector and market capitalization
Report issue











